Established in 1991, Sinobright Pharma distributes and trades a broad range of active pharmaceutical ingredients, including paracetamol, rifampicin, norfloxacin, metronidazole, trimethoprim, sulfadoxine, sucralfate, spiramycin base, piracetam, and PVP K30, supported by a technical team of PhD- and master's-level professionals experienced in drug registration and GMP compliance. The company serves markets across Central/South America, Europe, Australasia, Asia, the Middle East, Africa, and North America.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen